Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
12/27/2025
Telix Advances Regulatory Efforts with Positive China Phase 3 Data
12/27/2025
China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
12/27/2025
Zai Lab's COBENFY Approve in China for Schizophrenia
12/27/2025
GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval
12/27/2025
NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
12/27/2025
China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
12/23/2025
CSPC Announces China Approval for Daratumumab Injection
12/23/2025
Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...
12/23/2025
T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
12/23/2025
China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
12/22/2025
Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...
12/22/2025
Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...
12/18/2025
Rona Advances Dual-Targeting siRNA RN5681 Into Clinical Development
12/18/2025
HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...
12/18/2025
China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...
12/18/2025
Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...
12/18/2025
Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...
12/16/2025
China Approves Genzyme's Fenthosilan Sodium Injection
12/16/2025
InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...
12/15/2025
Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
12/15/2025
AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
12/15/2025
Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
12/15/2025
InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
12/12/2025
CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
12/12/2025
Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
12/12/2025
InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
12/11/2025
China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
12/11/2025
Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
12/11/2025
Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
12/11/2025
Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
Page:
1
/
21
Total number of articles:
609
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit